Full-Time
Manager – Molecular Operations
AI-driven precision medicine through clinical and molecular data analysis
Mid, Senior
Durham, NC, USA
- M.S. (physical, chemical, or biological science) + at least 4 years pertinent clinical lab experience (at least 2 of which are in the designated specialty)
- BS in clinical laboratory science, chemical, physical or biological sciences and at least 7 years of pertinent clinical lab experience
- Experience supervising others in a CLIA/CAP high-complexity laboratory
- Experience in Next Generation Sequencing
- Excellent communication skills
- Ability to delegate tasks to other
- Thrives in a fast-paced environment
- Ability to work with others to plan and carry out scientific programs
- Self-driven and works well in an interdisciplinary team with minimal direction
- Strong desire to build products that will save lives and change the course of cancer
- Coordinate the operational activities of a cutting-edge clinical laboratory to support a molecular workflow with rapid turnaround times. This role primarily oversees next-generation sequencing workflows for oncology panels
- Provides technical direction, mentoring, and professional guidance to laboratory employees
- Oversee initiation and, at times creation, of incident reports while leading full root cause analyses into batch failures
- Resolve technical, instrument, or unexpected tests results and ensures correctiveactions are taken whenever test systems deviate from the laboratory's established performance specifications
- Provide solutions to highly complex problems and apply a high degree of ingenuity,creativity and innovation
- Reviews daily, weekly, and monthly QC results and determines the validity of results,performs follow up as needed
- Maintain regulatory compliance within the lab, including CAP, CLIA, OSHA
- Develop and implement workflows for new assays, in collaboration with R&D
- Evaluate the competency of all testing personnel on an ongoing basis
Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.
Company Stage
Series G
Total Funding
$1.3B
Headquarters
Chicago, Illinois
Founded
2015